← SynDRA
DIOSCIN
SynDRA canonical compound SYN0010215 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CXCR3 |
| Mechanism of action | apoptosis stimulant |
All known targets
Mechanisms of action (all sources)
- apoptosis stimulant
- CXCR3 ANTAGONIST
Cross-references
Synonyms
- Collettiside III
- Dioscine
- CHEBI:74023
- CCRIS 4123
- UNII-3B95U4OLWV
- 3-O-(Rhaalpha1-4(Rhaalpha1-2)Glcbeta)-(25R)-spirost-5-en-3beta-ol
- 3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]-diosgenin
- 3-O-[alpha-L-Rhap-(1->4)-[alpha-L-Rhap-(1->2)]-beta-D-Glcp]-diosgenin
- (25R)-spirost-5-en-3beta-yl alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-mannopyranosyl-(1->4)]-beta-D-glucopyranoside
- 3B95U4OLWV
- AC1L3OGN
- Dioscin(Collettiside III)
- Dioscin (Collettiside III)
- GTPL840
- (+)-DIOSCIN
- (2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[(1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- Collettinside III
- 3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]-diosgenin
- 3-O-[alpha-L-Rhap-(1->4)-[alpha-L-Rhap-(1->2)]-beta-D-Glcp]-diosgenin
- (25R)-spirost-5-en-3beta-yl alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-mannopyranosyl-(1->4)]-beta-D-glucopyranoside
- PARIS III
- DIOSCIN [MI]
- DIOSCIN [WHO-DD]
- SCHEMBL526528
- CHEMBL507001
- Dioscin, >=95% (HPLC)
- HY-N0124
- BDBM50088500
- MFCD02094174
- s2379
- AKOS022168201
- Diosgenin bis-alpha-L-rhamnopyranosyl)-(1-2 and 1-4)-beta-D-glucopyranoside
- ZINC238809530
- CCG-270544
- C08897
- 057D604
- A880409
Look up DIOSCIN in the interactive SynDRA portal →